Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-017556
Filing Date
2020-07-15
Accepted
2020-07-15 16:30:54
Documents
3
Period of Report
2020-07-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1585
2 POWER OF ATTORNEY ea124205ex24_citius.htm EX-24 5482
3 GRAPHIC image_005.gif GRAPHIC 1061
  Complete submission text file 0001213900-20-017556.txt   10230
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Czuczman Myron (Reporting) CIK: 0001817716 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38174 | Film No.: 201029432